Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population

• Published in: Frontiers in cardiovascular medicine Vol. 9; p. 687555
• Main Authors: Soh, Rodney Yu-Hang, Sia, Ching-Hui, Djohan, Andie Hartanto, Lau, Rui-Huai, Ho, Pei-Ying, Neo, Jonathan Wen-Hui, Ho, Jamie Sin-Ying, Sim, Hui-Wen, Yeo, Tiong-Cheng, Tan, Huay-Cheem, Chan, Mark Yan-Yee, Loh, Joshua Ping-Yun
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 18.03.2022
• Subjects: anaemia; Asian; bleeding event; Cardiovascular Medicine; cardiovascular outcomes; percutaneous coronary intervention; percutaneous coronary intervention; anaemia; cardiovascular outcomes; Asian; bleeding event
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2022.687555

This study aimed to investigate the impact of anaemia on long-term clinical outcomes in patients who underwent semi-urgent and elective percutaneous coronary intervention (PCI) in an Asian population. Although the effects of anaemia on outcomes in Asian patients are well studied for acute coronary syndrome, its impact on Asian patients undergoing semi-urgent and elective PCI is unclear. This was a retrospective cohort study of patients who underwent semi-urgent and elective PCI from January 1, 2014, to December 31, 2015, at a tertiary academic centre. A total of 1,685 patients were included. They were stratified into three groups: normal (≥12 g/dL), intermediate (10-11.9 g/dL), and low (<10 g/dL) haemoglobin levels. Demographics, risk factors, and end-points including the 5-point major adverse cardiac and cerebrovascular events (MACCE) (all-cause death, subsequent stroke, myocardial infarction, congestive cardiac failure, and target lesion revascularisation), cardiovascular death, and bleeding events were analysed. Patients in intermediate and low haemoglobin level groups were older with more comorbidities. Compared to the normal haemoglobin level group, low haemoglobin level group patients were associated with an increased risk of composite endpoints of all-cause death, subsequent stroke, myocardial infarction, congestive cardiac failure, and target lesion revascularisation [adjusted hazard ratio (aHR) 1.89, 95% confidence interval (CI):1.22, 2.92; = 0.004]. This was driven by the increased risk of target lesions revascularisation observed in the low haemoglobin level group compared to the normal haemoglobin level group (aHR 17.74, 95% CI: 1.74, 180.80; = 0.015). The patients in the low haemoglobin level group were also associated with a higher risk of bleeding events compared to the normal haemoglobin level group (aHR 7.18, 95% CI: 1.13, 45.40; = 0.036). In our Asian cohort, patients with anaemia undergoing PCI were associated with a higher comorbid burden. Despite adjustments for comorbidities, these patients had higher mortality and worse cardiovascular outcomes following contemporary PCI.